1. Home
  2. AVXL vs YEXT Comparison

AVXL vs YEXT Comparison

Compare AVXL & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • YEXT
  • Stock Information
  • Founded
  • AVXL 2004
  • YEXT 2006
  • Country
  • AVXL United States
  • YEXT United States
  • Employees
  • AVXL N/A
  • YEXT N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • YEXT EDP Services
  • Sector
  • AVXL Health Care
  • YEXT Technology
  • Exchange
  • AVXL Nasdaq
  • YEXT Nasdaq
  • Market Cap
  • AVXL 956.7M
  • YEXT 1.0B
  • IPO Year
  • AVXL N/A
  • YEXT 2017
  • Fundamental
  • Price
  • AVXL $8.78
  • YEXT $8.77
  • Analyst Decision
  • AVXL Strong Buy
  • YEXT Strong Buy
  • Analyst Count
  • AVXL 2
  • YEXT 4
  • Target Price
  • AVXL $44.00
  • YEXT $9.44
  • AVG Volume (30 Days)
  • AVXL 944.5K
  • YEXT 1.2M
  • Earning Date
  • AVXL 08-12-2025
  • YEXT 09-08-2025
  • Dividend Yield
  • AVXL N/A
  • YEXT N/A
  • EPS Growth
  • AVXL N/A
  • YEXT N/A
  • EPS
  • AVXL N/A
  • YEXT N/A
  • Revenue
  • AVXL N/A
  • YEXT $449,657,000.00
  • Revenue This Year
  • AVXL N/A
  • YEXT $8.92
  • Revenue Next Year
  • AVXL N/A
  • YEXT $5.14
  • P/E Ratio
  • AVXL N/A
  • YEXT $145.54
  • Revenue Growth
  • AVXL N/A
  • YEXT 13.51
  • 52 Week Low
  • AVXL $5.03
  • YEXT $5.51
  • 52 Week High
  • AVXL $14.44
  • YEXT $9.20
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 39.78
  • YEXT 52.48
  • Support Level
  • AVXL $8.85
  • YEXT $8.62
  • Resistance Level
  • AVXL $9.69
  • YEXT $8.91
  • Average True Range (ATR)
  • AVXL 0.55
  • YEXT 0.21
  • MACD
  • AVXL -0.02
  • YEXT -0.05
  • Stochastic Oscillator
  • AVXL 1.82
  • YEXT 44.23

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: